148 related articles for article (PubMed ID: 29880282)
41. Targeted, triggered drug delivery to tumor and biofilm microenvironments.
Benoit DS; Koo H
Nanomedicine (Lond); 2016 Apr; 11(8):873-9. PubMed ID: 26987892
[No Abstract] [Full Text] [Related]
42. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.
Hao Y; Wang L; Zhang B; Li D; Meng D; Shi J; Zhang H; Zhang Z; Zhang Y
Int J Nanomedicine; 2016; 11():1759-78. PubMed ID: 27199556
[TBL] [Abstract][Full Text] [Related]
43. Supramolecular cancer nanotheranostics.
Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
[TBL] [Abstract][Full Text] [Related]
44. Liposomes-based Nanoplatform Enlarges Ultrasound-related Diagnostic and Therapeutic Precision.
Zhang Y; Fowlkes B
Curr Med Chem; 2022 Mar; 29(8):1331-1341. PubMed ID: 34348609
[TBL] [Abstract][Full Text] [Related]
45. Nanomedicine for cutaneous tumors - lessons since the successful treatment of the Kaposi sarcoma.
F Longo JP; Lucci CM; Muehlmann LA; Azevedo RB
Nanomedicine (Lond); 2018 Dec; 13(23):2957-2959. PubMed ID: 30500301
[No Abstract] [Full Text] [Related]
46. Supramolecular Nanotheranostics.
Chen X; Zheng G; Cheng J; Yang YY
Theranostics; 2019; 9(11):3014-3016. PubMed ID: 31244939
[TBL] [Abstract][Full Text] [Related]
47. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
[TBL] [Abstract][Full Text] [Related]
48. How are we applying nanogel composites in biomedicine?
Kar M; Molina M; Calderón M
Nanomedicine (Lond); 2017 Jul; 12(14):1627-1630. PubMed ID: 28635377
[No Abstract] [Full Text] [Related]
49. Magnetic nanoparticles for magnetic drug targeting.
Lyer S; Singh R; Tietze R; Alexiou C
Biomed Tech (Berl); 2015 Oct; 60(5):465-75. PubMed ID: 26351783
[TBL] [Abstract][Full Text] [Related]
50. A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization.
Samiei Foroushani M; Niroumand N; Karimi Shervedani R; Yaghoobi F; Kefayat A; Torabi M
Bioelectrochemistry; 2019 Dec; 130():107347. PubMed ID: 31437809
[TBL] [Abstract][Full Text] [Related]
51. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
[TBL] [Abstract][Full Text] [Related]
52. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
[TBL] [Abstract][Full Text] [Related]
53. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
54. Synthesis of dual-functional targeting probes for cancer theranostics based on iron oxide nanoparticles coated by centipede-like polymer connected with pH-responsive anticancer drug.
Zhao H; Li Z; Yang B; Wang J; Li Y
J Biomater Sci Polym Ed; 2015; 26(16):1178-89. PubMed ID: 26249213
[TBL] [Abstract][Full Text] [Related]
55. Targeting liposomes toward novel pediatric anticancer therapeutics.
Federman N; Denny CT
Pediatr Res; 2010 May; 67(5):514-9. PubMed ID: 20118828
[TBL] [Abstract][Full Text] [Related]
56. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
[TBL] [Abstract][Full Text] [Related]
57. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
Hao Y; Wang L; Zhang B; Zhao H; Niu M; Hu Y; Zheng C; Zhang H; Chang J; Zhang Z; Zhang Y
Nanotechnology; 2016 Jan; 27(2):025101. PubMed ID: 26629735
[TBL] [Abstract][Full Text] [Related]
58. Liposomes for drug delivery to mitochondria.
Boddapati SV; D'Souza GG; Weissig V
Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
[TBL] [Abstract][Full Text] [Related]
59. Interlocked systems in nanomedicine.
Ornelas-Megiatto C; Becher TB; Megiatto JD
Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
[TBL] [Abstract][Full Text] [Related]
60. Paramagnetic CuS hollow nanoflowers for T
Zhang H; Chen Y; Cai Y; Liu J; Liu P; Li Z; An T; Yang X; Liang C
Biomater Sci; 2018 Dec; 7(1):409-418. PubMed ID: 30488900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
